Femasys Inc (FEMY)

Mar 24, 2026

Femasys (NASDAQ: FEMY) director discloses notes, warrants and share stake - Stock Titan

Mar 24, 2026

Mar 21, 2026

Femasys Inc. Enters Omnibus Amendment and Issues Series D-1 Warrants – SEC 8-K Filing March 2026 - Minichart

Mar 21, 2026

Mar 20, 2026

Femasys amends warrants and notes, appoints new director to board - Investing.com

Mar 20, 2026

Mar 20, 2026

Femasys (NASDAQ: FEMY) director receives stock options for 35,200 shares - Stock Titan

Mar 20, 2026

Mar 20, 2026

Femasys Amends Financing Terms and Issues New Warrants - TipRanks

Mar 20, 2026

Mar 20, 2026

Femasys enters omnibus amendment and consent agreement on March 19, 2026SEC filing - marketscreener.com

Mar 20, 2026

Mar 20, 2026

Femasys Enters Omnibus Amendment And Consent Agreement On March 19, 2026SEC Filing - TradingView

Mar 20, 2026

Mar 20, 2026

Femasys Amends Notes and Warrants; Issues 16.38M New Warrants at $0.58 to Holders - TradingView

Mar 20, 2026

Mar 20, 2026

Femasys (FEMY) grants 16.4M Series D-1 warrants and appoints new independent director - Stock Titan

Mar 20, 2026

Mar 19, 2026

Femasys Inc. announced that it has received $12 million in funding - marketscreener.com

Mar 19, 2026

Mar 19, 2026

Femasys appoints anesthesiologist to board of directors By Investing.com - Investing.com South Africa

Mar 19, 2026

Mar 18, 2026

PharmaCyte Biotech (PMCB) logs neutral Form 4 as 10% FEMASYS (FEMY) owner - Stock Titan

Mar 18, 2026

Mar 18, 2026

Femasys (NASDAQ: FEMY) director Joshua Silverman files neutral Form 4 - Stock Titan

Mar 18, 2026

Mar 18, 2026

PharmaCyte Biotech (FEMY) reports 7.87% stake including warrants - Stock Titan

Mar 18, 2026

Mar 18, 2026

Femasys Inc. Appoints Dr. Kenneth D. Eichenbaum to Board of Directors - marketscreener.com

Mar 18, 2026

Mar 18, 2026

Femasys appoints anesthesiologist to board of directors - Investing.com

Mar 18, 2026

Mar 18, 2026

Femasys Appoints Dr. Kenneth D. Eichenbaum to Board of Directors - Bitget

Mar 18, 2026

Mar 18, 2026

Femasys Inc. Appoints Kenneth D. Eichenbaum, M.D., M.S.E., to Board of Directors - Quiver Quantitative

Mar 18, 2026

Mar 18, 2026

Femasys appoints Dr. Kenneth D. Eichenbaum to board of directors - marketscreener.com

Mar 18, 2026

Mar 18, 2026

Femasys Appoints Dr. Kenneth D. Eichenbaum To Board Of Directors - TradingView

Mar 18, 2026

Mar 16, 2026

Femasys begins enrollment in pivotal trial for FemBloc device - Investing.com Nigeria

Mar 16, 2026

Mar 16, 2026

Jeremy Alexander Sipos Net Worth (2026) - GuruFocus

Mar 16, 2026

Mar 12, 2026

Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN

Mar 12, 2026

Mar 11, 2026

Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - MSN

Mar 11, 2026

Mar 11, 2026

Femasys begins enrollment in pivotal trial for FemBloc device By Investing.com - Investing.com Australia

Mar 11, 2026

Mar 10, 2026

Non-surgical permanent birth control FemBloc begins final U.S. trial - Stock Titan

Mar 10, 2026

Mar 06, 2026

Femasys Inc. (NASDAQ:FEMY) Receives $5.50 Average Price Target from Analysts - Defense World

Mar 06, 2026

Mar 04, 2026

Femasys (NASDAQ:FEMY) Now Covered by Analysts at Lake Street Capital - Defense World

Mar 04, 2026

Mar 03, 2026

Lake Street initiates Femasys stock coverage with buy rating By Investing.com - Investing.com Australia

Mar 03, 2026

Mar 03, 2026

Lake Street initiates Femasys stock coverage with buy rating - Investing.com

Mar 03, 2026

Mar 01, 2026

FEMY Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 01, 2026

Feb 28, 2026

FEMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Feb 28, 2026

Feb 28, 2026

FEMY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 28, 2026

Feb 27, 2026

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Feb 27, 2026

Feb 27, 2026

Femasys’s FemBloc Pivotal Trial Update: What Investors Should Watch in Women’s Health - TipRanks

Feb 27, 2026

Feb 26, 2026

Femasys Announces FemBloc® Permanent Birth Control Has - GlobeNewswire

Feb 26, 2026

Feb 26, 2026

New non-surgical permanent birth control clears key global quality hurdle - Stock Titan

Feb 26, 2026

Feb 25, 2026

Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access - Bitget

Feb 25, 2026

Feb 24, 2026

Sentiment Watch: Is Femasys Inc stock undervalued right nowJuly 2025 Setups & Low Risk Investment Opportunities - baoquankhu1.vn

Feb 24, 2026

Feb 24, 2026

Femasys receives CPT code approval for infertility treatment - Investing.com India

Feb 24, 2026

Feb 24, 2026

Femasys receives CPT code approval for infertility treatment By Investing.com - Investing.com Australia

Feb 24, 2026

Feb 23, 2026

FEMY SEC FilingsFEMASYS INC 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 23, 2026

Feb 23, 2026

Trend Review: Can Femasys Inc benefit from deglobalization2025 Big Picture & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Feb 23, 2026

Feb 23, 2026

AMA procedure code supports new infertility option for over 10M US women - Stock Titan

Feb 23, 2026

Feb 22, 2026

Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination - Bitget

Feb 22, 2026

Feb 20, 2026

Femasys (FEMY) CEO awarded 729,000 RSUs vesting through 2027 - Stock Titan

Feb 20, 2026

Feb 20, 2026

Femasys (NASDAQ: FEMY) CFO receives 342,000 restricted stock units - Stock Titan

Feb 20, 2026

Feb 17, 2026

Femasys (FEMY) CTO reports common stock and option holdings in Form 3 - Stock Titan

Feb 17, 2026

Feb 14, 2026

How cyclical is Femasys Inc.’s revenue streamJuly 2025 News Drivers & Technical Pattern Based Buy Signals - mfd.ru

Feb 14, 2026

Feb 13, 2026

Femasys : Shareholder Update – 2025 in Review - marketscreener.com

Feb 13, 2026